Sheila A. Ryder

732 total citations
31 papers, 537 citations indexed

About

Sheila A. Ryder is a scholar working on Pharmacology, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Sheila A. Ryder has authored 31 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 9 papers in Geriatrics and Gerontology and 7 papers in Molecular Biology. Recurrent topics in Sheila A. Ryder's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sheila A. Ryder is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sheila A. Ryder collaborates with scholars based in Ireland, Australia and United Kingdom. Sheila A. Ryder's co-authors include John F. Gilmer, Deirdre M. D’Arcy, Imran Sulaiman, Catherine J. Byrne, Richard W. Costello, Elaine MacHale, Fiona Boland, Bernard Silke, Johnny McHugh and Helen Enright and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Sheila A. Ryder

31 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila A. Ryder Ireland 13 216 141 128 76 73 31 537
Taofikat B. Agbabiaka United Kingdom 10 124 0.6× 37 0.3× 67 0.5× 61 0.8× 41 0.6× 12 666
Kevin Sneed United States 15 94 0.4× 37 0.3× 32 0.3× 191 2.5× 58 0.8× 39 1.0k
Xianmei Zhou China 16 59 0.3× 57 0.4× 340 2.7× 158 2.1× 11 0.2× 48 670
Mohammad Fathalipour Iran 15 34 0.2× 35 0.2× 87 0.7× 115 1.5× 34 0.5× 43 648
S. O. Shaheen United Kingdom 12 35 0.2× 347 2.5× 221 1.7× 72 0.9× 22 0.3× 20 716
Sinem Ezgi Gülmez Türkiye 12 81 0.4× 58 0.4× 105 0.8× 50 0.7× 9 0.1× 30 647
Bhavin Patel United States 17 117 0.5× 18 0.1× 142 1.1× 112 1.5× 27 0.4× 68 899
Yun Kim South Korea 11 43 0.2× 49 0.3× 45 0.4× 72 0.9× 15 0.2× 59 491
Ahmed S. Ali Saudi Arabia 13 46 0.2× 20 0.1× 52 0.4× 53 0.7× 16 0.2× 77 502
David F. Lehmann United States 13 166 0.8× 17 0.1× 27 0.2× 59 0.8× 10 0.1× 37 464

Countries citing papers authored by Sheila A. Ryder

Since Specialization
Citations

This map shows the geographic impact of Sheila A. Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila A. Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila A. Ryder more than expected).

Fields of papers citing papers by Sheila A. Ryder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila A. Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila A. Ryder. The network helps show where Sheila A. Ryder may publish in the future.

Co-authorship network of co-authors of Sheila A. Ryder

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila A. Ryder. A scholar is included among the top collaborators of Sheila A. Ryder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila A. Ryder. Sheila A. Ryder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ryder, Sheila A., et al.. (2020). Development of Professional Attributes through Integration of Science and Practice at First-Year Pharmacy Level. SHILAP Revista de lepidopterología. 9(1). 4–4. 1 indexed citations
3.
Greene, Garrett, Elaine MacHale, Breda Cushen, et al.. (2019). Personalized Biofeedback on Inhaler Adherence and Technique by Community Pharmacists: A Cluster Randomized Clinical Trial. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 635–644. 43 indexed citations
4.
Grimes, Tamasine, Martin Henman, Máire O’Dwyer, et al.. (2019). Design and Implementation of an Integrated Competency-Focused Pharmacy Programme: A Case Report. SHILAP Revista de lepidopterología. 7(3). 121–121. 11 indexed citations
5.
Byrne, Catherine J., Jason A. Roberts, Brett McWhinney, et al.. (2017). Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy. Clinical Microbiology and Infection. 23(9). 674.e7–674.e13. 33 indexed citations
6.
Byrne, Catherine J., Brett McWhinney, Jérôme Fennell, et al.. (2017). Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy. Journal of Antimicrobial Chemotherapy. 73(4). 995–1003. 44 indexed citations
7.
Sulaiman, Imran, Jansen N. Seheult, Elaine MacHale, et al.. (2016). A Method to Calculate Adherence to Inhaled Therapy that Reflects the Changes in Clinical Features of Asthma. Annals of the American Thoracic Society. 13(11). 1894–1903. 40 indexed citations
8.
Sulaiman, Imran, Jansen N. Seheult, Elaine MacHale, et al.. (2016). Irregular and Ineffective: A Quantitative Observational Study of the Time and Technique of Inhaler Use. The Journal of Allergy and Clinical Immunology In Practice. 4(5). 900–909.e2. 49 indexed citations
9.
10.
Byrne, Catherine J., Jérôme Fennell, Helen Enright, et al.. (2015). Teicoplanin use in adult patients with haematological malignancy: Exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity. International Journal of Antimicrobial Agents. 46(4). 406–412. 26 indexed citations
11.
Ryder, Sheila A., et al.. (2013). Tumour vasculature targeting agents in hybrid/conjugate drugs. Angiogenesis. 16(3). 503–524. 30 indexed citations
12.
Ryder, Sheila A., et al.. (2012). Asthma management in the community pharmacy setting in Ireland. International Journal of Clinical Pharmacy. 34(1). 186–186. 2 indexed citations
13.
Ryder, Sheila A., et al.. (2012). Community pharmacy services at the primary-secondary care interface. International Journal of Clinical Pharmacy. 34(1). 211–212. 1 indexed citations
14.
Harbison, Joseph, et al.. (2012). Audit and feedback to improve the quality of prescription writing. International Journal of Clinical Pharmacy. 34(1). 256. 2 indexed citations
15.
Ryder, Sheila A., et al.. (2012). Profiling harmful medication errors in an acute Irish teaching hospital. Irish Journal of Medical Science (1971 -). 181(4). 491–497. 2 indexed citations
16.
Ryder, Sheila A., et al.. (2010). Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability. Bioorganic & Medicinal Chemistry. 18(3). 1045–1053. 16 indexed citations
17.
Glynn, Shirley M., et al.. (2009). Measuring and benchmarking safety culture: application of the safety attitudes questionnaire to an acute medical admissions unit. Irish Journal of Medical Science (1971 -). 178(4). 433–439. 51 indexed citations
18.
Ryder, Sheila A., et al.. (2008). Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase. Chemico-Biological Interactions. 175(1-3). 293–297. 4 indexed citations
19.
Gilmer, John F., et al.. (2008). Pharmacological effects of a novel isosorbide-based butyrylcholinesterase inhibitor. Chemico-Biological Interactions. 175(1-3). 231–234. 6 indexed citations
20.
Kirby, Brian P., Sheila A. Ryder, Nikolaus Seiler, Jacques Renault, & Graham G. Shaw. (2004). N1-Dansyl-spermine: a potent polyamine antagonist. Brain Research. 1011(1). 69–73. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taofikat B. Agbabiaka Breakdown of academic impact, for papers by Kevin Sneed Breakdown of academic impact, for papers by Xianmei Zhou Breakdown of academic impact, for papers by Mohammad Fathalipour Breakdown of academic impact, for papers by S. O. Shaheen Breakdown of academic impact, for papers by Sinem Ezgi Gülmez Breakdown of academic impact, for papers by Bhavin Patel Breakdown of academic impact, for papers by Yun Kim Breakdown of academic impact, for papers by Ahmed S. Ali Breakdown of academic impact, for papers by David F. Lehmann
Rankless by CCL
2026